Schrodinger Inc at Piper Sandler Healthcare Conference (Virtual) Transcript
Okay. Thank you for joining us for the 33rd Piper Sandler Healthcare Conference. My name is Do Kim. I am a senior biotech analyst with Piper Sandler. And I have the pleasure to welcome Schrödinger's CEO, Ramy Farid; CFO, Joel Lebowitz; and Chief Biomedical Scientist, Karen Akinsanya. Thank you all for being here with us today. I think that most of the intended audience are already familiar with Schrödinger and what you do, but just in case, why don't we start with an overview of the business and platform please?
¶ -
Sure, of course. I'd just give a brief update. As you said, most people probably know the story. So we've developed a computational platform based on physics-based methods that we have shown now in many different ways is really transforming the way therapeutics and materials are discovered. This is really allowing scientists to discover superior therapeutics and materials in a much faster and cheaper than traditional methods.
So what we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |